Finland· FI-REL-REL53263
Tigecycline Accord
A tigecycline product containing tigecycline, registered in Finland by Accord Healthcare S.L.U.. The same ATC class is registered in 17 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tigecycline is registered in 17 of 19 countries.
Countries holding a registration under ATC J01AA12 (tigecycline), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Tigecycline · ATC J01AA12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tigecycline costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- Finland: $3.05 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tigecycline · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$3.05
The record
At a glance
Fimea (Finland)- Active substance
- Tigecycline
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Finland (FI)
- ATC code
- J01AA12
- ATC class
- Tigecycline
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for tigecycline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tigecycline · interactions on record
65 records
- 3 severe
- 13 moderate
- 24 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Sodium picosulfateA06AB08moderate
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tigecycline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTIGECYCLINE ACCORDAccord Healthcare S.L.U., Barcelona
- SpainTIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandTigecycline AccordAccord Healthcare S.L.U.
- United KingdomTigecycline 50mg powder for solution for infusion vialsAccord-UK Ltd
- SwedenTigecycline Accord 50 mg Pulver till infusionsvätska, lösningAccord Healthcare S.L.U.
- IrelandTigecycline 50 mg Powder for solution for infusionNoridem Enterprises Limited
- BelgiumTigecyclin Sandoz 50 mgSandoz
- IcelandTigecycline AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Tigecyclin Aptapharma, Tigecyclin Hikma
- Bulgaria · Тигециклин Аптафарма, Тигециклин Ромфарм
- Cyprus · Tigecycline Aptapharma, Tigecycline Sapiens
- Czechia · Tigecycline Aptapharma, Tigecycline Mylan
- Germany · Tigecyclin Amarox, Tigecyclin Carinopharm
- Denmark · Tigecycline Eql Pharma
- Estonia · Tigecycline Inteli, Tigecycline Norameda
- Spain · Tigeciclina Cipla, Tigeciclina Hikma
- France · Tigecycline Amarox, Tigecycline Hikma
- United Kingdom (Northern Ireland) · Tigecycline Aft Pharma Uk, Tigecycline Amarox
- Greece · Digazor, Tigecycline Anfarm
- Croatia · Tigeciklin Aptapharma, Tigeciklin Galenika
- Hungary · Tigeciklin Galenika, Tigeciklin Noridem
- Ireland · Tigecycline Noridem Enterprises
- Iceland · Tigecycline Accord, Tygacil
- Italy · Tigeciclina Amarox, Tigeciclina Cipla
- Liechtenstein · Tigecycline Accord, Tygacil
- Lithuania · Tigecycline Inteli, Tigecycline Norameda
- Latvia · Tigecycline Inteli, Tigecycline Norameda
- Malta · Tigecycline Anfarm, Tigecycline Aptapharma
- Netherlands · Tigecycline Amarox, Tigecycline Hikma
- Norway · Tigecycline Accord, Tigecycline Eql Pharma
- Poland · Tigecycline Aptapharma, Tigecycline Norameda
- Portugal · Tigeciclina Cipla, Tigeciclina Hikma
- Romania · Tigeciclină Aptapharma, Tigeciclina Atb
- Sweden · Tigecycline Eql Pharma, Tigecycline Viatris
- Slovenia · Tigeciklin Aptapharma, Tigeciklin Diagonalis
- Slovakia · Tigecycline Aptapharma, Tigecycline Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78caedb9-667a-4b75-a344-93aecdc10993 GET /v1/drugs/78caedb9-667a-4b75-a344-93aecdc10993?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.1",
"form": "infuusiokuiva-aine, liuosta varten",
"route": "Laskimoon",
"ddd_unit": "g",
"strength": "50 mg",
"atc_label": "tigesykliini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/19/1394/001-002",
"fimea_rel_id": "REL53263",
"authorised_at": "2020-04-17"
}See everything about tigecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.